The first-in-man clinical trial targeting Alzheimer's Tau protein

The first-in-man clinical trial targeting Alzheimer's Tau protein:

Dementia Big
For the first time, targeting the other feature of Alzheimer’s disease, tau, has given fruitful results. In an unprecedented study, active vaccination in humans has resulted in a favorable immune response in 29 out of the 30 patients with only minor side effects.

http://ift.tt/2hye30V